Lori Isom, professor and chair of University of Michigan Medical School’s Department of Pharmacology has been elected to the National Academy of Medicine, one of the highest honors for a clinician or scientist.
“I am very honored and humbled to have been chosen by my peers for inclusion in the National Academy of Medicine,” Isom says. “This election is a tribute to the group of incredibly talented students and postdocs who have trained in my lab, to the brilliant research faculty members who help to run my research program every day, to our scientific collaborators,”
“Especially Jack Parent at the University of Michigan, and to our patients with Dravet syndrome and their families. I am also grateful to my husband, Kelley, and daughters, Helena and Audrey, who have been unwavering in their support of my career.”
The academy recognizes individuals who have demonstrated outstanding professional achievement and commitment to service and who have made major contributions to the advancement of medical sciences, health care, and public health.
Isom is the Maurice H. Seevers Collegiate Professor of Pharmacology, professor of molecular and integrative physiology, and professor of neurology. She has served as director of the program in biomedical sciences and assistant dean for graduate education at the U-M Medical School.
Her research program focuses on voltage-gated sodium channel function and the roles of sodium channel gene variants in developmental and epileptic encephalopathy, including a rare disease called Dravet syndrome.
“To be elected to the National Academy is an incredible honor and could not go to a more deserving, accomplished individual,” says Marschall Runge, dean of the U-M Medical School and CEO of Michigan Medicine. “Dr. Isom is a pillar of our research and education community, and we are grateful for her leadership.”
